Advanced HR+ HER2 Negative Breast Carcinoma
2 clinical trials · Condition
◉ Watch Advanced HR+ HER2 Negative Breast Carcinoma
| Record | Firm | Date |
|---|---|---|
| Advanced Breast Cancer Study of CDK4/6 Inhibitor Combined With Endocrine Therapy Endocrine Therapy in HR+/HER2- Advanced Breast Cancer (NCT05295043) | Tianjin Medical University Cancer Institute and Hospital | 2022-12-10 |
| H (Trastuzumab or Biosimilar) Combined With CDK4/6 Inhibitor + AI±OFS in the Treatment of HR+HER2+ Advanced Breast Cancer Efficacy and Safety: a Chinese Multi-center Real World Study (NCT05167643) | Tianjin Medical University Cancer Institute and Hospital | 2022-01-23 |
Track Advanced HR+ HER2 Negative Breast Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.